NO993468L - Syntetiske peptid-epitoper fra proteinet fra Pre-M/M fra dengue-virus - Google Patents
Syntetiske peptid-epitoper fra proteinet fra Pre-M/M fra dengue-virusInfo
- Publication number
- NO993468L NO993468L NO993468A NO993468A NO993468L NO 993468 L NO993468 L NO 993468L NO 993468 A NO993468 A NO 993468A NO 993468 A NO993468 A NO 993468A NO 993468 L NO993468 L NO 993468L
- Authority
- NO
- Norway
- Prior art keywords
- protein
- virus
- dengue
- peptides
- demonstrated
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 101710085938 Matrix protein Proteins 0.000 title abstract 5
- 101710127721 Membrane protein Proteins 0.000 title abstract 5
- 241000725619 Dengue virus Species 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 241000699670 Mus sp. Species 0.000 abstract 4
- 241000710815 Dengue virus 2 Species 0.000 abstract 3
- 230000028993 immune response Effects 0.000 abstract 2
- 241000710831 Flavivirus Species 0.000 abstract 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 abstract 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000002788 anti-peptide Effects 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 230000009696 proliferative response Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1997013A CU22683A1 (es) | 1997-01-15 | 1997-01-15 | Epítopes de la proteína pre-m/m del virus del dengue, péptidos sintéticos, proteínas quiméricas y sus usos |
| PCT/CU1998/000001 WO1998031814A1 (es) | 1997-01-15 | 1998-01-13 | Epitopes de la proteina pre-m/m del virus del dengue, peptidos sinteticos |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO993468D0 NO993468D0 (no) | 1999-07-14 |
| NO993468L true NO993468L (no) | 1999-09-14 |
Family
ID=5459193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO993468A NO993468L (no) | 1997-01-15 | 1999-07-14 | Syntetiske peptid-epitoper fra proteinet fra Pre-M/M fra dengue-virus |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6383488B1 (no) |
| EP (1) | EP0966535B1 (no) |
| JP (1) | JP3647048B2 (no) |
| CN (1) | CN1198933C (no) |
| AT (1) | ATE284444T1 (no) |
| AU (1) | AU743414B2 (no) |
| BR (1) | BR9807486A (no) |
| CA (1) | CA2277816A1 (no) |
| CU (1) | CU22683A1 (no) |
| DE (1) | DE69828032T2 (no) |
| ES (1) | ES2235310T3 (no) |
| HK (1) | HK1025999A1 (no) |
| MY (1) | MY120971A (no) |
| NO (1) | NO993468L (no) |
| WO (1) | WO1998031814A1 (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU23245A1 (es) | 2001-07-16 | 2007-10-17 | Inst De Medicina Tropical Pedr | CADENAS QUIMéRICAS CODIFICANTES PARA PROTEINAS INDUCTORAS DE EFECTOS CONTRA VIRUS. PREPARADOS UTILIZANDO PROTEINAS QUIMéRICAS |
| KR101042458B1 (ko) * | 2001-12-04 | 2011-06-16 | 벤처 테크놀로지스 에스디엔 비에이치디 | 플라비바이러스 ｎｓ1 서브유닛 백신 |
| EP1454988A1 (en) * | 2003-03-03 | 2004-09-08 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Infectious flavivirus pseudo-particles containing functional prM-E envelope proteins |
| US7281274B2 (en) * | 2003-10-16 | 2007-10-09 | Lmp Media Llc | Electronic media distribution system |
| WO2006025990A2 (en) * | 2004-07-27 | 2006-03-09 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Diseases Control And Prevention | Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes and methods for their use |
| CU23578A1 (es) | 2005-09-16 | 2010-09-30 | Ct Ingenieria Genetica Biotech | Proteína de la cápsida del virus dengue inductora de respuesta protectora y composición vacunal |
| CU23630A1 (es) | 2006-10-30 | 2011-02-24 | Ct Ingenieria Genetica Biotech | Moléculas peptídicas quiméricas con propiedades antivirales contra los virus de la familia flaviviridae |
| WO2009024534A2 (en) * | 2007-08-17 | 2009-02-26 | Intercell Ag | Japanese encephalitis virus (jev) and tick-borne encephalitis virus (tbev) peptides stimulating human t cell responses |
| CU20080028A6 (es) | 2008-02-29 | 2011-02-24 | Ct Ingenieria Genetica Biotech | Compuestos químicos obtenidos in silico para la preparación de composiciones farmacéuticas para atenuar o inhibir la infección por virus dengue y otros flavivirus |
| WO2010043977A2 (en) * | 2008-10-13 | 2010-04-22 | Institute For Research In Biomedicine | Dengue virus neutralizing antibodies and uses thereof |
| CN101921310B (zh) * | 2009-06-15 | 2014-03-12 | 温州医学院 | 登革病毒特异性hla-a2限制性表位肽及应用 |
| WO2011133112A1 (en) * | 2010-04-20 | 2011-10-27 | National University Of Singapore | Cell penetrating peptide derived from the premembrane protein of flavivirus |
| BR112013030637A2 (pt) * | 2011-05-26 | 2018-06-12 | Inst De Medicina Molecular | peptídeo derivado do vírus da dengue (denv) e métodos para a inibição da replicação de flavivírus |
| CU24188B1 (es) * | 2012-12-27 | 2016-07-29 | Ct De Ingeniería Genética Y Biotecnología | Composición vacunal contra el virus dengue |
| US10053493B2 (en) * | 2013-06-26 | 2018-08-21 | The University Of North Carolina At Chapel Hill | Methods and compositions for dengue virus vaccines |
| TWI769185B (zh) * | 2016-10-27 | 2022-07-01 | 海樂源有限公司 | 登革熱類病毒顆粒、抗登革熱病毒抗體、及含其之組合物 |
| CN116082499B (zh) * | 2021-11-08 | 2023-10-27 | 东莞市朋志生物科技有限公司 | 一种抗登革ns1蛋白的抗体及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1996040933A1 (en) * | 1995-06-07 | 1996-12-19 | The Government Of The United States Of America, Represented By The Secretary Department Of Health And Human Services | Infectious dengue 2 virus pdk-53 as quadravalent vaccine |
-
1997
- 1997-01-15 CU CU1997013A patent/CU22683A1/es unknown
-
1998
- 1998-01-13 JP JP53348698A patent/JP3647048B2/ja not_active Expired - Fee Related
- 1998-01-13 US US09/341,833 patent/US6383488B1/en not_active Expired - Fee Related
- 1998-01-13 BR BR9807486A patent/BR9807486A/pt not_active Application Discontinuation
- 1998-01-13 CN CNB988032031A patent/CN1198933C/zh not_active Expired - Fee Related
- 1998-01-13 AT AT98900843T patent/ATE284444T1/de not_active IP Right Cessation
- 1998-01-13 DE DE69828032T patent/DE69828032T2/de not_active Expired - Fee Related
- 1998-01-13 EP EP98900843A patent/EP0966535B1/en not_active Expired - Lifetime
- 1998-01-13 WO PCT/CU1998/000001 patent/WO1998031814A1/es active IP Right Grant
- 1998-01-13 ES ES98900843T patent/ES2235310T3/es not_active Expired - Lifetime
- 1998-01-13 CA CA002277816A patent/CA2277816A1/en not_active Abandoned
- 1998-01-13 AU AU56499/98A patent/AU743414B2/en not_active Ceased
- 1998-01-15 MY MYPI98000163A patent/MY120971A/en unknown
-
1999
- 1999-07-14 NO NO993468A patent/NO993468L/no not_active Application Discontinuation
-
2000
- 2000-08-22 HK HK00105273A patent/HK1025999A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU5649998A (en) | 1998-08-07 |
| JP2001508457A (ja) | 2001-06-26 |
| CU22683A1 (es) | 2001-07-20 |
| CA2277816A1 (en) | 1998-07-23 |
| CN1249781A (zh) | 2000-04-05 |
| CN1198933C (zh) | 2005-04-27 |
| JP3647048B2 (ja) | 2005-05-11 |
| NO993468D0 (no) | 1999-07-14 |
| ES2235310T3 (es) | 2005-07-01 |
| DE69828032T2 (de) | 2005-12-01 |
| US6383488B1 (en) | 2002-05-07 |
| MY120971A (en) | 2005-12-30 |
| BR9807486A (pt) | 2000-03-21 |
| HK1025999A1 (en) | 2000-12-01 |
| ATE284444T1 (de) | 2004-12-15 |
| EP0966535A1 (en) | 1999-12-29 |
| WO1998031814A1 (es) | 1998-07-23 |
| DE69828032D1 (de) | 2005-01-13 |
| AU743414B2 (en) | 2002-01-24 |
| EP0966535B1 (en) | 2004-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO993468L (no) | Syntetiske peptid-epitoper fra proteinet fra Pre-M/M fra dengue-virus | |
| Berasain et al. | Fasciola hepatica: parasite-secreted proteinases degrade all human IgG subclasses: determination of the specific cleavage sites and identification of the immunoglobulin fragments produced | |
| HRP20200871T1 (hr) | Izmjenjeni rsv f proteini i postupci njihove uporabe | |
| US7670766B2 (en) | Early detection of flaviviruses using the NS1 glycoprotein | |
| CA2623329A1 (en) | Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response | |
| Costa et al. | DNA vaccines against dengue virus based on the ns1 gene: the influence of different signal sequences on the protein expression and its correlation to the immune response elicited in mice | |
| ECSP064643A (es) | Proteinas de fusion de glp-1 | |
| DE112006000677A5 (de) | Rekombinante Expression von Proteinen in einer disulfidverbrückten, zweikettigen Form | |
| NO20063026L (no) | Antistoffer | |
| NZ591612A (en) | Prevention, treatment and diagnosis of p.gingivalis infection with peptides | |
| DK1278534T3 (da) | Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1 | |
| Aaskov et al. | Serologically defined linear epitopes in the envelope protein of dengue 2 (Jamaica strain 1409) | |
| Sun et al. | Identification of two linear B-cell epitopes from West Nile virus NS1 by screening a phage-displayed random peptide library | |
| CN109182380A (zh) | 杆状病毒表达的猪瘟e2亚单位疫苗的制备方法及应用 | |
| DE69928064D1 (de) | Mimotopen der hypervariabele region des e2 glykoproteins von hcv und deren verwendungen | |
| DK1417222T3 (da) | Isolerede polypeptider baseret på den neutraliserende epitop af p17-proteinet fra HIV egnet til vacciner samt neutraliserende anti-p17-antistoffer, der specifikt genkender nævnte neutraliserende epitop | |
| ATE357526T1 (de) | Modifizierte hcv peptid-impfstoffe | |
| DE69836647D1 (de) | Methode zur herstellung von (poly)peptiden unter verwendung von verkürzten varianten von sv40 'large' t antigen mit einem intakten n terminus | |
| Dueñas‐Carrera et al. | Immunological evaluation of Escherichia coli‐derived hepatitis C virus second envelope protein (E2) variants | |
| TH35001A (th) | เอพิโทป pre-m/m ของ dengue virus, เปปไทด์สังเคราะห์ ไคเมอริกโปรตีนและการใช้สิ่งที่กล่าว | |
| Truyen et al. | Studies on the role of linear epitopes in neutralization of alphaviruses | |
| WO2004056316A3 (en) | Vaccines against hiv-1 tat protein to generate neutralizing antibodies | |
| RU2221873C2 (ru) | Способ получения каталитических антител (варианты), антигены для иммунизации и нуклеотидная последовательность | |
| EP1310512A3 (en) | Hcv core protein sequences | |
| Martínez et al. | Humoral immune response against a hepatitis C Virus Envelope E2 variant expressed in Escherichia coli |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |